Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (31-40 of 418) with videos related to

Pageof 42
Sort By:
Drugs in Context|April 27, 2019
Second-line treatment options in hepatocellular carcinomaDonatella Marino, Clizia Zichi, Marco Audisio, et al.
Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.
Translational Lung Cancer Research|July 23, 2021
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysisGiorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinomaBruno Daniele, Mena Annunziata, Emiddio Barletta, et al.
International Journal of Oncology|May 27, 2014
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review)Massimo Di Maio, Filippo De Marinis, Fred R Hirsch, et al.
The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2012
Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxelMassimo Di Maio, Maciej Krzakowski, Ronan Fougeray, et al.
Journal of Clinical Gastroenterology|October 24, 2002
Hepatocellular carcinoma: systemic treatmentsMassimo Di Maio, Ermelinda De Maio, Francesco Perrone, et al.
Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.
Expert Review of Anticancer Therapy|October 14, 2020
Luteinized thecoma (thecomatosis) with sclerosing peritonitis: a systematic review of the literature of the last 25 yearsLeonardo Muratori, Elena Trevisi, Marco Donatello Delcuratolo, et al.
Pageof 42

Showing results (31-40 of 418) with videos related to

Sort By:
Pageof 42
Drugs in Context|April 27, 2019
Second-line treatment options in hepatocellular carcinomaDonatella Marino, Clizia Zichi, Marco Audisio, et al.
Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.
Translational Lung Cancer Research|July 23, 2021
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysisGiorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinomaBruno Daniele, Mena Annunziata, Emiddio Barletta, et al.
International Journal of Oncology|May 27, 2014
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review)Massimo Di Maio, Filippo De Marinis, Fred R Hirsch, et al.
The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2012
Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxelMassimo Di Maio, Maciej Krzakowski, Ronan Fougeray, et al.
Journal of Clinical Gastroenterology|October 24, 2002
Hepatocellular carcinoma: systemic treatmentsMassimo Di Maio, Ermelinda De Maio, Francesco Perrone, et al.
Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.
Expert Review of Anticancer Therapy|October 14, 2020
Luteinized thecoma (thecomatosis) with sclerosing peritonitis: a systematic review of the literature of the last 25 yearsLeonardo Muratori, Elena Trevisi, Marco Donatello Delcuratolo, et al.
Pageof 42